InvestorsHub Logo
Followers 10
Posts 472
Boards Moderated 0
Alias Born 08/02/2012

Re: LongRun8 post# 2168

Thursday, 06/18/2015 8:43:29 AM

Thursday, June 18, 2015 8:43:29 AM

Post# of 8631
This is a very nice addition to the Board. NVAX continues to bring in strategic players to prepare for commercialization. That way once these Ph2 (and, subsequently, Ph3) trials are completed, and assuming FDA approval, they will be able to hit the ground running and really get their vaccines some market share.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News